In Silico Approaches for Predicting Adme Properties

A drug requires a suitable pharmacokinetic profile to be efficacious in vivo in humans. The relevant pharmacokinetic properties include the absorption, distribution, metabolism, and excretion (ADME) profile of the drug. This chapter provides an overview of the definition and meaning of key ADME properties, recent models developed to predict these properties, and a guide as to how to select the most appropriate model(s) for a given query. Many tools using the state-of-the-art in silico methodology are now available to users, and it is anticipated that the continual evolution of these tools will provide greater ability to predict ADME properties in the future. However, caution must be exercised in applying these tools as data are generally available only for “successful” drugs, i.e., those that reach the marketplace, and little supplementary information, such as that for drugs that have a poor pharmacokinetic profile, is available. The possibilities of using these methods and possible integration into toxicity prediction are explored.

[1]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[2]  M. Schulz,et al.  Therapeutic and toxic blood concentrations of more than 500 drugs. , 1997, Die Pharmazie.

[3]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[4]  S. Ekins,et al.  Progress in predicting human ADME parameters in silico. , 2000, Journal of pharmacological and toxicological methods.

[5]  Ana Martínez,et al.  Prediction of Drug Half-life Values of Antihistamines Based on the CODES/Neural Network Model , 2000 .

[6]  M. Medina-Hernández,et al.  Retention pharmacokinetic and pharmacodynamic parameter relationships of antihistamine drugs using biopartitioning micellar chromatography. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[7]  S. Agatonovic-Kustrin,et al.  Molecular descriptors that influence the amount of drugs transfer into human breast milk. , 2002, Journal of pharmaceutical and biomedical analysis.

[8]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[9]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[10]  U. Norinder,et al.  Computational approaches to the prediction of the blood-brain distribution. , 2002, Advanced drug delivery reviews.

[11]  Gonzalo Colmenarejo,et al.  In silico prediction of drug‐binding strengths to human serum albumin , 2003, Medicinal research reviews.

[12]  Yi Li,et al.  In silico ADME/Tox: why models fail , 2003, J. Comput. Aided Mol. Des..

[13]  Mark T. D. Cronin,et al.  A Hierarchical QSAR Model for Urinary Excretion of Drugs in Humans as a Predictive Tool for Biotransformation , 2003 .

[14]  David A. Winkler,et al.  Neural networks in ADME and toxicity prediction , 2004 .

[15]  J. Duffy,et al.  Prediction of Pharmacokinetic Parameters in Drug Design and Toxicology , 2004 .

[16]  Franco Lombardo,et al.  Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. , 2004, Journal of medicinal chemistry.

[17]  M. Cronin,et al.  Quantitative structure‐pharmacokinetic relationship modelling: apparent volume of distribution , 2004, The Journal of pharmacy and pharmacology.

[18]  Martin P. Payne,et al.  Computer-Based Methods for the Prediction of Chemical Metabolism and Biotransformation within Biological Organisms , 2004 .

[19]  Mark T. D. Cronin,et al.  Predicting Chemical Toxicity and Fate , 2004 .

[20]  J. V. Turner,et al.  Pharmacokinetic parameter prediction from drug structure using artificial neural networks. , 2004, International journal of pharmaceutics.

[21]  Zhi-Wei Cao,et al.  Effect of Selection of Molecular Descriptors on the Prediction of Blood-Brain Barrier Penetrating and Nonpenetrating Agents by Statistical Learning Methods , 2005, J. Chem. Inf. Model..

[22]  Scott D. Kahn,et al.  Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.

[23]  Sean Ekins,et al.  Computational prediction of human drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.

[24]  M T D Cronin,et al.  Structure-Based Methods for the Prediction of the Dominant P450 Enzyme in Human Drug Biotransformation: Consideration of CYP3A4, CYP2C9, CYP2D6 , 2005, SAR and QSAR in environmental research.

[25]  A. Ray,et al.  In silico strategies for modeling membrane transporter function. , 2005, Drug discovery today.

[26]  Ernesto Callegari,et al.  A comprehensive listing of bioactivation pathways of organic functional groups. , 2005, Current drug metabolism.

[27]  Huabei Zhang A New Approach for the Tissue-Blood Partition Coefficients of Neutral and Ionized Compounds , 2005, J. Chem. Inf. Model..

[28]  Miguel A. Cabrera,et al.  A topological substructural approach for the prediction of P-glycoprotein substrates. , 2006, Journal of pharmaceutical sciences.

[29]  T. Murakami,et al.  Expression and function of efflux drug transporters in the intestine. , 2006, Pharmacology & therapeutics.

[30]  Marcel J. de Groot,et al.  Designing better drugs: predicting cytochrome P450 metabolism. , 2006 .

[31]  Nigel J Waters,et al.  Quantitative structure activity relationships in drug metabolism. , 2006, Current topics in medicinal chemistry.

[32]  Anne Hersey,et al.  Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning. , 2006, Journal of medicinal chemistry.

[33]  Judith C Madden,et al.  Structure-based methods for the prediction of drug metabolism , 2006, Expert opinion on drug metabolism & toxicology.

[34]  Wei Zhang,et al.  Recent advances in computational prediction of drug absorption and permeability in drug discovery. , 2006, Current medicinal chemistry.

[35]  Alexander Hillisch,et al.  In Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS Hits , 2006, ChemMedChem.

[36]  Alexander Tropsha,et al.  QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation. , 2006, Journal of medicinal chemistry.

[37]  M. Abraham,et al.  Air to brain, blood to brain and plasma to brain distribution of volatile organic compounds: linear free energy analyses. , 2006, European journal of medicinal chemistry.

[38]  S C Basak,et al.  Prediction of tissue: air partition coefficients — theoretical vs . experimental methods , 2006, SAR and QSAR in environmental research.

[39]  M Paul Gleeson,et al.  In silico human and rat Vss quantitative structure-activity relationship models. , 2006, Journal of medicinal chemistry.

[40]  S. Ekins Systems-ADME/Tox: resources and network approaches. , 2006, Journal of pharmacological and toxicological methods.

[41]  M. Abraham,et al.  A data base for partition of volatile organic compounds and drugs from blood/plasma/serum to brain, and an LFER analysis of the data. , 2006, Journal of pharmaceutical sciences.

[42]  Z R Li,et al.  Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods. , 2006, Journal of molecular graphics & modelling.

[43]  Matthew D. Segall,et al.  ADMET Property Prediction: The State of the Art and Current Challenges , 2006 .

[44]  D. Mills,et al.  A quantitative structure–activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors , 2007, SAR and QSAR in environmental research.

[45]  John C Dearden,et al.  In silico prediction of ADMET properties: how far have we come? , 2007, Expert opinion on drug metabolism & toxicology.

[46]  Sue Gibbs,et al.  Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. , 2007, Current drug metabolism.

[47]  Lars Carlsson,et al.  State-of-the-art Tools for Computational Site of Metabolism Predictions: Comparative Analysis, Mechanistical Insights, and Future Applications , 2007, Drug metabolism reviews.

[48]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery, 7. Prediction of Oral Absorption by Correlation and Classification , 2007, J. Chem. Inf. Model..

[49]  Ursula Gundert-Remy,et al.  Physiologically-based Kinetic Modelling (PBK Modelling): Meeting the 3Rs Agenda , 2007, Alternatives to laboratory animals : ATLA.

[50]  Han van de Waterbeemd,et al.  Time‐Series QSAR Analysis of Human Plasma Protein Binding Data , 2007 .

[51]  J C Madden,et al.  Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier , 2007, SAR and QSAR in environmental research.

[52]  Yiyu Cheng,et al.  Identifying P-Glycoprotein Substrates Using a Support Vector Machine Optimized by a Particle Swarm , 2007, J. Chem. Inf. Model..

[53]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery, 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules? , 2007, J. Chem. Inf. Model..

[54]  Adriano D Andricopulo,et al.  Hologram QSAR model for the prediction of human oral bioavailability. , 2007, Bioorganic & medicinal chemistry.

[55]  Mark L. Lewis,et al.  Predicting Penetration Across the Blood-Brain Barrier from Simple Descriptors and Fragmentation Schemes , 2007, J. Chem. Inf. Model..

[56]  Yvan Vander Heyden,et al.  Benchmarking of QSAR Models for Blood-Brain Barrier Permeation , 2007, J. Chem. Inf. Model..

[57]  Balázs Sarkadi,et al.  The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). , 2008, Drug discovery today.

[58]  Edward H. Kerns,et al.  Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization , 2008 .

[59]  J C Madden,et al.  An evaluation of global QSAR models for the prediction of the toxicity of phenols to Tetrahymena pyriformis. , 2008, Chemosphere.

[60]  Xin Wu,et al.  Predicting the volume of distribution of drugs in humans. , 2008, Current drug metabolism.

[61]  M. Gleeson Generation of a set of simple, interpretable ADMET rules of thumb. , 2008, Journal of medicinal chemistry.

[62]  Lujia Han,et al.  An evaluation of mathematical models for predicting skin permeability. , 2008, Journal of pharmaceutical sciences.

[63]  Kairui Feng,et al.  The Simcyp® Population-based ADME Simulator , 2009 .